Chatterjee N - Search Results

1

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, Chatterjee N, Yeager M, Chanock SJ, Rothman N. Wang SS, et al. Among authors: chatterjee n. Cancer Res. 2006 Oct 1;66(19):9771-80. doi: 10.1158/0008-5472.CAN-06-0324. Cancer Res. 2006. PMID: 17018637

2

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

Chatterjee N, Shih J, Hartge P, Brody L, Tucker M, Wacholder S. Chatterjee N, et al. Genet Epidemiol. 2001 Sep;21(2):123-38. doi: 10.1002/gepi.1022. Genet Epidemiol. 2001. PMID: 11507721

3

Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.

Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R. Peters U, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1267-74. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11751444

4

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Hartge P, et al. Among authors: chatterjee n. Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004. Epidemiology. 2002. PMID: 11964925

5

Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studies.

Wacholder S, Chatterjee N, Hartge P. Wacholder S, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):885-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223433

6

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Anderson WF, et al. Among authors: chatterjee n. Breast Cancer Res Treat. 2002 Nov;76(1):27-36. doi: 10.1023/a:1020299707510. Breast Cancer Res Treat. 2002. PMID: 12408373

7

Apportioning causes, targeting populations and predicting risks: population attributable fractions.

Chatterjee N, Hartge P. Chatterjee N, et al. Eur J Epidemiol. 2003;18(10):933-5. doi: 10.1023/a:1025863607725. Eur J Epidemiol. 2003. PMID: 14598922 No abstract available.

8

Adjustment for competing risk in kin-cohort estimation.

Chatterjee N, Hartge P, Wacholder S. Chatterjee N, et al. Genet Epidemiol. 2003 Dec;25(4):303-13. doi: 10.1002/gepi.10269. Genet Epidemiol. 2003. PMID: 14639700

9

Urinary mutagenicity and colorectal adenoma risk.

Peters U, DeMarini DM, Sinha R, Brooks LR, Warren SH, Chatterjee N, Rothman N. Peters U, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1253-6. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652290

10

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Peters U, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,119 results

Search Page

Filters